AdventHealth Shawnee Mission introduces a novel behavioral health treatment—transcranial magnetic stimulation—for patients with depression or obsessive-compulsive disorder resistant to conventional therapies. Dr. Umang Shah, a psychiatrist at AdventHealth Psychiatry and Wellbeing, highlights the limited success rates of medications and psychotherapy, prompting the adoption of this noninvasive treatment. Administered via BrainsWay’s Deep Transcranial Magnetic Stimulation, the therapy targets specific brain regions associated with depression. Patients undergo 36 sessions over 12 weeks, reporting a 50% or more improvement in 75% of cases. Positive testimonials underscore the treatment’s efficacy, offering hope for those previously unresponsive to traditional approaches.